Lymphoid Organs, MHC Molecules, B and T Cell Activation

Lymphoid Organs

Lymphoid organs are the sites where lymphocytes (B cells and T cells) are produced, mature, and interact with antigens. They are crucial components of the immune system, responsible for initiating adaptive immune responses. These organs are broadly classified into primary (or central) and secondary (or peripheral) lymphoid organs.

Primary Lymphoid Organs

Primary lymphoid organs are where lymphocytes develop from progenitor cells and acquire their specific antigen receptors. They are the "birthplaces" and "schools" of lymphocytes. In mammals, the primary lymphoid organs are the bone marrow and the thymus.

Bone Marrow

The bone marrow is the principal site of hematopoiesis, the process of blood cell formation. All lymphocytes, as well as other blood cells like red blood cells and myeloid cells, originate from hematopoietic stem cells (HSCs) residing in the bone marrow. For B cells, the bone marrow is not only the site of origin but also the site of maturation. Immature B cells develop into mature, naive B cells within the bone marrow microenvironment. They undergo selection processes to eliminate self-reactive cells before migrating to secondary lymphoid organs.

Thymus

The thymus is a bilobed organ located in the thoracic cavity, superior to the heart. It is the primary site for T cell maturation. Immature T cells, called thymocytes, migrate from the bone marrow to the thymus. Here, they undergo a complex developmental process involving positive and negative selection. Positive selection ensures that T cells can recognize self-MHC molecules, which is essential for their function. Negative selection eliminates T cells that react too strongly to self-antigens presented by self-MHC molecules. Only T cells that have successfully passed these selection processes mature into functional, naive T cells and leave the thymus to populate secondary lymphoid organs.

Secondary Lymphoid Organs

Secondary lymphoid organs are the sites where mature lymphocytes encounter antigens, become activated, proliferate, and differentiate into effector cells and memory cells. These organs are strategically located throughout the body to maximize the chances of antigen encounter. The main secondary lymphoid organs include lymph nodes, the spleen, and mucosal-associated lymphoid tissues (MALT).

Lymph Nodes

Lymph nodes are small, bean-shaped organs distributed along the lymphatic vessels. They act as filters for lymph fluid draining from tissues. Lymph enters the lymph node through afferent lymphatic vessels and percolates through the node's parenchyma. Lymphocytes circulate continuously through the lymph nodes. Antigens that enter the tissue spaces are transported by lymphatic vessels to the draining lymph node. Here, antigens are captured by antigen-presenting cells (APCs) like dendritic cells and macrophages, and presented to lymphocytes. This interaction initiates an adaptive immune response, leading to lymphocyte proliferation and differentiation within the lymph node. Effector lymphocytes then exit the lymph node via efferent lymphatic vessels or the bloodstream.

Spleen

The spleen is the largest lymphoid organ, located in the upper left quadrant of the abdomen. It filters blood rather than lymph. The spleen has two main functional components: the red pulp, which removes old and damaged red blood cells, and the white pulp, which is the site of immune responses to blood-borne antigens. The white pulp consists of lymphoid tissue surrounding arterioles, forming periarteriolar lymphoid sheaths (PALS) rich in T cells, and lymphoid follicles containing B cells. Antigens circulating in the blood are trapped in the spleen by specialized APCs, leading to the activation of lymphocytes within the white pulp.

Mucosal-Associated Lymphoid Tissues (MALT)

MALT comprises lymphoid tissues strategically located in the mucosal linings of the respiratory, gastrointestinal, and urogenital tracts. These areas are constant interfaces with the external environment and are therefore exposed to a large number of antigens, including commensal microbes and pathogens. Examples of MALT include Peyer's patches in the small intestine, tonsils, adenoids, and appendix. MALT plays a critical role in mucosal immunity, preventing the entry of pathogens and maintaining tolerance to harmless antigens. Lymphocytes in MALT are activated by antigens encountered at mucosal surfaces, leading to the production of IgA antibodies, which are crucial for mucosal defense.

MHC Molecules

Major Histocompatibility Complex (MHC) molecules are a set of cell surface proteins essential for the adaptive immune system to recognize foreign molecules. In humans, MHC is also known as the Human Leukocyte Antigen (HLA) complex. MHC molecules present peptide fragments (antigens) to T cells. There are two main classes of MHC molecules: Class I and Class II.

MHC Class I Molecules

MHC Class I molecules are found on the surface of almost all nucleated cells in the body. Their primary role is to present intracellularly-derived peptides (e.g., from viral proteins or tumor antigens) to CD8+ cytotoxic T lymphocytes (CTLs). When a cell is infected with a virus, viral proteins are degraded in the cytosol by the proteasome, transported into the endoplasmic reticulum (ER), and loaded onto MHC Class I molecules. These peptide-MHC complexes are then transported to the cell surface. Recognition of a foreign peptide presented by MHC Class I signals to the CD8+ T cell that the cell is infected and should be eliminated.

Structure: MHC Class I molecules consist of a transmembrane heavy chain (alpha chain) non-covalently associated with a smaller protein called beta-2-microglobulin. The alpha chain has three domains (α1, α2, α3) and a transmembrane region. The peptide-binding groove is formed by the α1 and α2 domains.

MHC Class II Molecules

MHC Class II molecules are primarily expressed on professional antigen-presenting cells (APCs), including dendritic cells, macrophages, and B cells. Their function is to present extracellularly-derived peptides (e.g., from bacteria or soluble proteins) to CD4+ helper T lymphocytes. Antigens are taken up by APCs via phagocytosis or endocytosis, degraded in lysosomes, and the resulting peptides are loaded onto MHC Class II molecules in specialized endosomal compartments. The peptide-MHC Class II complexes are then transported to the cell surface. Recognition of a foreign peptide presented by MHC Class II activates CD4+ T cells, which help orchestrate the immune response by secreting cytokines and assisting B cells and CD8+ T cells.

Structure: MHC Class II molecules are composed of two non-covalently associated transmembrane chains: an alpha chain and a beta chain, each with two domains (α1, α2 and β1, β2). The peptide-binding groove is formed by the α1 and β1 domains.

MHC Restriction

A fundamental concept in T cell recognition is MHC restriction. T cells recognize a foreign peptide only when it is presented by a self-MHC molecule. CD8+ T cells are restricted to recognizing peptides presented by MHC Class I molecules, while CD4+ T cells are restricted to recognizing peptides presented by MHC Class II molecules. This restriction is a consequence of the T cell receptor (TCR) structure and the selection processes that occur in the thymus.

B and T Cell Activation

B and T cell activation are the key events that initiate adaptive immune responses. While both cell types are lymphocytes and part of the adaptive immune system, their activation pathways and roles differ significantly.

B Cell Activation

B cells are responsible for humoral immunity, producing antibodies that target extracellular pathogens and toxins. The activation of a B cell typically requires two signals:

1. Signal 1: Antigen Binding

   Each B cell expresses a unique B cell receptor (BCR) on its surface, which is essentially a membrane-bound antibody molecule. The BCR can recognize and bind to a specific antigen. When an antigen binds to the BCR, it triggers the first signal for activation. For many protein antigens, this binding also leads to the B cell internalizing the antigen-BCR complex via receptor-mediated endocytosis.

2. Signal 2: T Cell Help (for T-dependent antigens)

   Most protein antigens (T-dependent antigens) require help from activated CD4+ T helper cells for full B cell activation and antibody production. After internalizing and processing the antigen, the B cell acts as an APC. It presents peptide fragments of the antigen on its MHC Class II molecules. If a T helper cell with a TCR that recognizes this specific peptide-MHC Class II complex encounters the B cell, it becomes activated. The activated T helper cell then provides the second signal for B cell activation, usually through direct contact (e.g., CD40-CD40L interaction) and the release of cytokines (e.g., IL-4, IL-21). This T cell help is crucial for robust antibody production, class switching, and affinity maturation.

   For some antigens, particularly polysaccharides and lipopolysaccharides (T-independent antigens), B cell activation can occur with only Signal 1, without T cell help. However, the antibody response is generally weaker and lacks the diversity and affinity maturation seen with T-dependent antigens.

Upon successful activation, B cells proliferate extensively (clonal expansion) and differentiate into:

• Plasma cells: These are terminally differentiated effector cells that secrete large amounts of antibodies specific for the activating antigen.
• Memory B cells: These long-lived cells persist after the infection is cleared and provide immunological memory, allowing for a faster and stronger response upon re-exposure to the same antigen.

T Cell Activation

T cells are responsible for cell-mediated immunity and regulate immune responses. There are two main types of T cells: CD4+ helper T cells and CD8+ cytotoxic T lymphocytes. Both require specific signals for activation, primarily delivered by APCs.

Activation of CD4+ Helper T Cells

CD4+ T cells recognize peptide antigens presented by MHC Class II molecules on APCs.

1. Signal 1: TCR-MHC/Peptide Interaction

   The T cell receptor (TCR) on the CD4+ T cell recognizes a specific peptide presented by an MHC Class II molecule on an APC. The CD4 co-receptor on the T cell also binds to the MHC Class II molecule, stabilizing the interaction.

2. Signal 2: Co-stimulation

   For full activation, T cells require co-stimulatory signals from APCs. The most important co-stimulatory pathway involves the interaction between B7 molecules (CD80/CD86) on the APC and the CD28 molecule on the T cell. This signal is crucial to prevent anergy (a state of unresponsiveness) and ensure a robust immune response. APCs upregulate B7 molecules upon encountering danger signals (e.g., PAMPs through Toll-like receptors).

3. Signal 3: Cytokines

   Cytokines secreted by the APC and other cells in the microenvironment influence the differentiation of the activated CD4+ T cell into specific subsets (e.g., Th1, Th2, Th17, Treg). These subsets have distinct cytokine profiles and effector functions.

Activated CD4+ T cells proliferate and differentiate into effector helper T cells, which secrete cytokines to help activate other immune cells (B cells, macrophages, CD8+ T cells), and memory T cells.

Activation of CD8+ Cytotoxic T Lymphocytes (CTLs)

CD8+ T cells recognize peptide antigens presented by MHC Class I molecules, which are found on most nucleated cells, including APCs. The activation process is similar to that of CD4+ T cells but involves CD8 co-receptors and MHC Class I molecules.

1. Signal 1: TCR-MHC/Peptide Interaction

   The TCR on the CD8+ T cell recognizes a specific peptide presented by an MHC Class I molecule on an APC or infected cell. The CD8 co-receptor on the T cell binds to the MHC Class I molecule, stabilizing the interaction.

2. Signal 2: Co-stimulation

   Similar to CD4+ T cells, CD8+ T cells require co-stimulatory signals, primarily from B7 molecules on APCs interacting with CD28 on the T cell, for full activation. In some cases, help from CD4+ T cells is also required for optimal CD8+ T cell activation, especially against viral infections. This can occur when APCs present antigens to both CD4+ and CD8+ T cells, or when CD4+ T cells provide cytokines that promote CD8+ T cell activation.

Once activated, CD8+ T cells proliferate and differentiate into effector CTLs. CTLs are cytotoxic and kill target cells (e.g., virus-infected cells or tumor cells) by releasing cytotoxic molecules like perforin and granzymes, or by inducing apoptosis through Fas-FasL interactions. They also differentiate into memory CD8+ T cells.